• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型多发性内分泌肿瘤患者的多发性面部血管纤维瘤和胶原瘤。

Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.

作者信息

Darling T N, Skarulis M C, Steinberg S M, Marx S J, Spiegel A M, Turner M

机构信息

Dermatology Branch, National Cancer Institute, National Institutes of Health Bethesda, MD, USA.

出版信息

Arch Dermatol. 1997 Jul;133(7):853-7.

PMID:9236523
Abstract

OBJECTIVES

To evaluate patients with multiple endocrine neoplasia type 1 (MEN 1) for cutaneous manifestations.

DESIGN

Survey during a 3-year period.

SETTING

The National Institutes of Health, a tertiary referral research hospital in Bethesda Md.

PATIENTS

A consecutive sample of 32 individuals with previously diagnosed MEN1 who were not preselected for the presence of skin lesions were examined for cutaneous abnormalities. None of the patients or family members were diagnosed as having tuberous sclerosis.

INTERVENTIONS

Lesions were identified by clinical appearance, photographed, and confirmed histologically.

MAIN OUTCOME MEASURE

To determine the frequency of skin lesions in patients with MEN1.

RESULTS

Multiple facial angiofibromas were observed in 28 (88%) of the patients with MEN1, with 16 patients (50%) having 5 or more. Angiofibromas were clinically and histologically identical to those in individuals with tuberous sclerosis. Collagenomas were observed in 23 patients (72%). Also observed were cafe au lait macules in 12 patients (38%), lipomas in 11 patients (34%), confetti-like hypopigmented macules in 2 patients (6%), and multiple gingival papules in 2 patients (6%).

CONCLUSIONS

Multiple angiofibromas, collagenomas, lipomas, confetti-like hypopigmented macules and multiple gingival papules are cutaneous manifestations of MEN1 and should be looked for in both family members of patients with MEN1 and individuals with hyperparathyroidism of other MEN1-associated tumors. Multiple angiofibromas can no longer be considered pathognomonic for tuberous sclerosis. The observation of angiofibromas in individuals without tuberous sclerosis necessitates further biochemical testing for MEN1.

摘要

目的

评估1型多发性内分泌腺瘤病(MEN 1)患者的皮肤表现。

设计

为期3年的调查。

地点

位于马里兰州贝塞斯达的国立卫生研究院,一家三级转诊研究医院。

患者

连续抽取32例先前诊断为MEN1的患者样本,这些患者未因皮肤病变而预先筛选,检查其皮肤异常情况。患者及其家庭成员均未被诊断为患有结节性硬化症。

干预措施

通过临床表现识别病变,拍照,并进行组织学确认。

主要观察指标

确定MEN1患者皮肤病变的发生率。

结果

在32例MEN1患者中,28例(88%)观察到多发性面部血管纤维瘤,其中16例(50%)有5个或更多。血管纤维瘤在临床和组织学上与结节性硬化症患者的相同。23例患者(72%)观察到胶原瘤。还观察到12例患者(38%)有咖啡斑,11例患者(34%)有脂肪瘤,2例患者(6%)有五彩纸屑样色素减退斑,2例患者(6%)有多个牙龈丘疹。

结论

多发性血管纤维瘤、胶原瘤、脂肪瘤、五彩纸屑样色素减退斑和多个牙龈丘疹是MEN1的皮肤表现,在MEN1患者的家庭成员以及患有其他MEN1相关肿瘤的甲状旁腺功能亢进患者中均应予以关注。多发性血管纤维瘤不能再被视为结节性硬化症的特征性表现。在无结节性硬化症的个体中观察到血管纤维瘤需要对MEN1进行进一步的生化检测。

相似文献

1
Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.1型多发性内分泌肿瘤患者的多发性面部血管纤维瘤和胶原瘤。
Arch Dermatol. 1997 Jul;133(7):853-7.
2
Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1.与1型多发性内分泌肿瘤综合征相关的皮肤病变
J Eur Acad Dermatol Venereol. 2008 Jul;22(7):835-8. doi: 10.1111/j.1468-3083.2008.02578.x. Epub 2008 Apr 24.
3
Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene.1型多发性内分泌肿瘤患者的皮肤肿瘤显示MEN1基因的等位基因缺失。
J Invest Dermatol. 1998 Apr;110(4):438-40. doi: 10.1046/j.1523-1747.1998.00140.x.
4
Segmental tuberous sclerosis presenting as unilateral facial angiofibromas.表现为单侧面部血管纤维瘤的节段性结节性硬化症。
J Am Acad Dermatol. 2003 Aug;49(2 Suppl Case Reports):S164-6. doi: 10.1067/mjd.2003.146.
5
[Multiple and unilateral angiofibromas of the face: forme fruste of Bourneville tuberous sclerosis].[面部多发性和单侧性血管纤维瘤:结节性硬化症的顿挫型]
Ann Dermatol Venereol. 1998 May;125(5):325-7.
6
Angiofibromas in multiple endocrine neoplasia type 1.1型多发性内分泌肿瘤中的血管纤维瘤
Dermatol Online J. 2012 Dec 15;18(12):20.
7
Angiofibromas with multiple epidermoid cysts in tuberous sclerosis: new mutation or post-traumatic?结节性硬化症中伴有多个表皮样囊肿的血管纤维瘤:新突变还是创伤后形成?
J Cutan Pathol. 2013 May;40(5):509-12. doi: 10.1111/cup.12103. Epub 2013 Feb 19.
8
Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dubé syndrome.多发性面部血管纤维瘤:Birt-Hogg-Dubé综合征的一种皮肤表现。
J Am Acad Dermatol. 2005 Aug;53(2 Suppl 1):S108-11. doi: 10.1016/j.jaad.2004.11.021.
9
Unilateral facial angiofibromas without other evidence of tuberous sclerosis: case report and review of the literature.无结节性硬化其他证据的单侧面部血管纤维瘤:病例报告及文献综述
Cutis. 2007 Oct;80(4):284-8.
10
Absence of signs of systemic involvement in four patients with bilateral multiple facial angiofibromas.四名双侧多发性面部血管纤维瘤患者无全身受累征象。
Am J Med Genet A. 2010 Mar;152A(3):657-64. doi: 10.1002/ajmg.a.33320.

引用本文的文献

1
Multimodal Imaging Approach to MEN-1 Syndrome-Associated Tumors.多模态成像方法用于MEN-1综合征相关肿瘤
Diagnostics (Basel). 2025 May 3;15(9):1164. doi: 10.3390/diagnostics15091164.
2
Genotype-phenotype correlation in multiple endocrine neoplasia type 1.1型多发性内分泌腺瘤病的基因型-表型相关性
JCI Insight. 2025 Feb 13;10(6):e176993. doi: 10.1172/jci.insight.176993.
3
Familial states of primary hyperparathyroidism: an update.家族性原发性甲状旁腺功能亢进症:最新进展。
J Endocrinol Invest. 2024 Sep;47(9):2157-2176. doi: 10.1007/s40618-024-02366-7. Epub 2024 Apr 18.
4
Lipomas: genetic basis of common skin lesions and their occurrence in rare diseases.脂肪瘤:常见皮肤病变的遗传基础及其在罕见疾病中的发生情况。
Postepy Dermatol Alergol. 2023 Aug;40(4):481-486. doi: 10.5114/ada.2023.129529. Epub 2023 Jul 15.
5
Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome.多发性内分泌腺瘤病 1 型综合征的皮肤损害及其他非内分泌表现。
Front Endocrinol (Lausanne). 2023 Jul 7;14:1191040. doi: 10.3389/fendo.2023.1191040. eCollection 2023.
6
Molecular and Clinical Spectrum of Primary Hyperparathyroidism.原发性甲状旁腺功能亢进的分子和临床谱。
Endocr Rev. 2023 Sep 15;44(5):779-818. doi: 10.1210/endrev/bnad009.
7
Approach of Multiple Endocrine Neoplasia Type 1 (MEN1) Syndrome-Related Skin Tumors.1型多发性内分泌腺瘤病(MEN1)综合征相关皮肤肿瘤的治疗方法。
Diagnostics (Basel). 2022 Nov 12;12(11):2768. doi: 10.3390/diagnostics12112768.
8
Beyond the "3 Ps": A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1.超越“3P”:对 1 型多发性内分泌肿瘤非内分泌表现的批判性评估。
Front Endocrinol (Lausanne). 2022 Oct 17;13:1029041. doi: 10.3389/fendo.2022.1029041. eCollection 2022.
9
Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity.MEN1 错义突变的多组学分析确定了 menin-MLL 和 menin-JunD 相互作用的破坏是分子发病机制的关键要求。
Epigenetics Chromatin. 2022 Aug 9;15(1):29. doi: 10.1186/s13072-022-00461-8.
10
Occult insulinoma with treatment refractory, severe hypoglycaemia in multiple endocrine neoplasia type 1 syndrome; difficulties faced during diagnosis, localization and management; a case report.1 型多发性内分泌腺瘤综合征伴治疗抵抗、严重低血糖的隐匿性胰岛素瘤;诊断、定位和治疗管理中面临的困难;病例报告。
BMC Endocr Disord. 2022 Mar 16;22(1):68. doi: 10.1186/s12902-022-00985-w.